257 related articles for article (PubMed ID: 17114072)
1. CT/MRI of neuroendocrine tumours.
Reznek RH
Cancer Imaging; 2006 Oct; 6(Spec No A):S163-77. PubMed ID: 17114072
[TBL] [Abstract][Full Text] [Related]
2. Imaging of neuroendocrine tumours (CT/MR/US).
Rockall AG; Reznek RH
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):43-68. PubMed ID: 17382265
[TBL] [Abstract][Full Text] [Related]
3. [Morphological imaging of gastroenteropancreatic neuroendocrine tumours].
Camera L; Bresciani M; Soscia E; Percopo V; Mainenti PP; Salvatore M
Minerva Endocrinol; 2001 Sep; 26(3):123-8. PubMed ID: 11753234
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET).
Kanakis G; Kamp K; Tsiveriotis K; Feelders RA; Zormpala A; de Herder WW; Kaltsas G
Clin Endocrinol (Oxf); 2013 Jun; 78(6):950-6. PubMed ID: 22970733
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types.
Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
Acta Oncol; 2004; 43(7):626-36. PubMed ID: 15545183
[TBL] [Abstract][Full Text] [Related]
7. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
Schillaci O; Corleto VD; Annibale B; Scopinaro F; Delle Fave G
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127
[TBL] [Abstract][Full Text] [Related]
8. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.
Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128
[TBL] [Abstract][Full Text] [Related]
9. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
Niederle MB; Hackl M; Kaserer K; Niederle B
Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
[TBL] [Abstract][Full Text] [Related]
10. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
[TBL] [Abstract][Full Text] [Related]
11. GEP-NETS update: functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs).
de Herder WW
Eur J Endocrinol; 2014 May; 170(5):R173-83. PubMed ID: 24723670
[TBL] [Abstract][Full Text] [Related]
12. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.
Kawamoto S; Shi C; Hruban RH; Choti MA; Schulick RD; Fishman EK; Siegelman SS
AJR Am J Roentgenol; 2011 Sep; 197(3):W482-8. PubMed ID: 21862776
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
Kaltsas G; Rockall A; Papadogias D; Reznek R; Grossman AB
Eur J Endocrinol; 2004 Jul; 151(1):15-27. PubMed ID: 15248818
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-EDDA/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors.
Gabriel M; Muehllechner P; Decristoforo C; von Guggenberg E; Kendler D; Prommegger R; Profanter C; Moncayo R; Virgolini I
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):237-44. PubMed ID: 16172569
[TBL] [Abstract][Full Text] [Related]
15. Imaging spectrum of bronchial carcinoid--a case of central bronchial obstructing lesion.
Ramachandran PV; Harigovind D; Shamsudeen H; Baburaj AK; Mohan K; Krishnadas KV; Achuthan V
J Indian Med Assoc; 2002 Jul; 100(7):461-2, 464. PubMed ID: 12674172
[TBL] [Abstract][Full Text] [Related]
16. Octreoscan in patients with bronchial carcinoid tumours.
Granberg D; Sundin A; Janson ET; Oberg K; Skogseid B; Westlin JE
Clin Endocrinol (Oxf); 2003 Dec; 59(6):793-9. PubMed ID: 14974924
[TBL] [Abstract][Full Text] [Related]
17. Standard imaging techniques for neuroendocrine tumors.
Bushnell DL; Baum RP
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):153-62, ix. PubMed ID: 21349416
[TBL] [Abstract][Full Text] [Related]
18. [Endoscopic ultrasonography in patients suspected of neuroendocrine tumours].
Ainsworth AP; Fristrup CW; Mortensen MB; Nielsen HO
Ugeskr Laeger; 2008 May; 170(22):1938-40. PubMed ID: 18513479
[TBL] [Abstract][Full Text] [Related]
19. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
